详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Current understanding on long non-coding RNAs in immune response to COVID-19

130| 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. [2]Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. Electronic address: chenjingmaomao111@163.com. [3]Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China. Electronic address: zhoujt521@163.com.

出处：

DOI：

ISSN：

摘要：

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic threatening the lives and health of people worldwide. Currently, there are no effective therapies or available vaccines for COVID-19. The molecular mechanism causing acute immunopathological diseases in severe COVID-19 is being investigated. Long noncoding RNAs (lncRNAs) have been proven to be involved in many viral infections, such as hepatitis, influenza and acquired immune deficiency syndrome. Many lncRNAs present differential expression between normal tissue and virus-infected tissue. However, the role of lncRNAs in SARS-CoV-2 infection has not been fully elucidated. This study aimed to review the relationship between lncRNAs and viral infection, interferon and cytokine storms in COVID-19, hoping to provide novel insights into promising targets for COVID-19 treatment.Copyright © 2022. Published by Elsevier B.V.

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 4 区医学

小类 | 4 区病毒学

最新[2023]版：

大类 | 4 区医学

小类 | 4 区病毒学

JCR分区：

出版当年[2023]版：

Q3 VIROLOGY

最新[2023]版：

Q3 VIROLOGY

影响因子： 2.5 最新[2023版] 3.2 最新五年平均 2.5 出版当年[2023版] 3.2 出版当年五年平均 5 出版前一年[2022版]

第一作者：

第一作者机构： [1]Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：